Antimicrobial activity of an acetic and boric acid solution against Staphylococcus pseudintermedius

Incubation of 101 colony forming units/ml of Staphylococcus pseudintermedius in an undiluted, a 1:2 and a 1:4 diluted aqueous 2% acetic acid and 2% boric acid solution resulted in inactivation of the bacteria within 30, 60 and 120 minutes, respectively. This indicates that a combination of these acids might be useful for local treatment of S. pseudintermedius infections. Further clinical studies are necessary, however, to confirm these in vitro results

Transmission dynamics of methicillin-resistant Staphylococcus aureus in pigs

From the mid-2000s on, numerous studies have shown that methicillin-resistant Staphylococcus aureus (MRSA), renowned as human pathogen, has a reservoir in pigs and other livestock. In Europe and North America, clonal complex (CC) 398 appears to be the predominant lineage involved. Especially worrisome is its capacity to contaminate humans in close contact with affected animals. Indeed, the typical multi-resistant phenotype of MRSA CC398 and its observed ability of easily acquiring genetic material suggests that MRSA CC398 strains with an increased virulence potential may emerge, for which few therapeutic options would remain. This questions the need to implement interventions to control the presence and spread of MRSA CC398 among pigs. MRSA CC398 shows a high but not fully understood transmission potential in the pig population and is able to persist within that population. Although direct contact is probably the main route for MRSA transmission between pigs, also environmental contamination, the presence of other livestock, the herd size, and farm management are factors that may be involved in the dissemination of MRSA CC398. The current review aims at summarizing the research that has so far been done on the transmission dynamics and risk factors for introduction and persistence of MRSA CC398 in farms

België ontsnapt niet aan het 'rabbit hemorrhagic disease virus-2'

Since 2016, an extensive spread of RHDV2, a virus variant of the classical rabbit hemorrhagic disease virus (RHDV) is ongoing in the Belgian rabbit population. Both variants of the virus usually cause acute death without prior symptoms. Vaccination against both variants of the virus is possible. In Belgium, only a vaccine protecting against the classical RHDV has been registered. On their own responsibility, veterinarians are allowed to import a vaccine protecting against RHDV2 that is registered in another EU member state, in accordance with the so-called legislative waterfall-system. The current epidemiological situation warrants preventive vaccination of rabbits against RHD. It should be noted that myxomatosis is currently rather neglected in view of the increased attention for the RHDV2 spread. Myxomatosis also still causes a high mortality in both wild and domesticated rabbits. Veterinarians should correctly inform the public about the two important viral diseases in rabbits and the possibilities for prevention